Involvement of CREB Binding Protein in Expression of Major Histocompatibility Complex Class II Genes via Interaction with the Class II Transactivator

REFERENCES

• Arany, Z., D. Newsome, E. Oldread, D. M. Livingston, and R. Eckner 1995. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374: 81–84.
   PubMed Web of Science ®Google Scholar
• Bannister, A. J., and T. Kouzarides 1996. The CBP co-activator is a histone acetyltransferase. Nature 384: 641–643.
   PubMed Web of Science ®Google Scholar
• Bayley, S. T., and J. S. Mymryk 1994. Adenovirus E1A proteins and transformation. Int. J. Oncol. 5: 425–444.
   PubMedGoogle Scholar
• Bhattacharya, S., R. Eckner, S. Grossman, E. Oldread, Z. Arany, A. D’Andrea, and D. M. Livingston 1996. Cooperation of Stat2 and p300/CBP in signaling induced by interferon-α. Nature 383: 344–347.
   PubMed Web of Science ®Google Scholar
• Bontron, S., C. Ucla, B. Mach, and V. Steimle 1997. Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy. Mol. Cell. Biol. 17: 4249–4258.
   PubMedGoogle Scholar
• Carey, M. 1998. The enhanceosome and transcriptional synergy. Cell 92: 5–8.
   PubMed Web of Science ®Google Scholar
• Celada, A., S. McKercher, and R. A. Maki 1993. Repression of major histocompatibility complex IA expression by glucocorticoids: the glucocorticoid receptor inhibits the DNA binding of the X box DNA binding protein. J. Exp. Med. 177: 691–698.
   PubMedGoogle Scholar
• Chang, C. H., J. D. Fontes, M. Peterlin, and R. A. Flavell 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180: 1367–1374.
   PubMedGoogle Scholar
• Chang, C. H., and R. A. Flavell 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 18: 765–767.
   Google Scholar
• Eckner, R., M. Ewen, D. Newsome, M. Gerdes, J. DeCaprio, J. Lawrence, and D. Livingstone 1994. Molecular cloning and functional analysis of the adenovirus E1A associated 300-Kd (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8: 869–884.
   PubMed Web of Science ®Google Scholar
• Fertsch-Ruggio, D., D. R. Schoenberg, and S. N. Vogel 1988. Induction of macrophage Ia antigen expression by rIFN-gamma and down-regulation by IFN-alpha/beta and dexamethasone are regulated transcriptionally. J. Immunol. 141: 1582–1589.
   PubMed Web of Science ®Google Scholar
• Fontes, J. D., B. Jiang, and B. M. Peterlin 1997. The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32. Nucleic Acids Res. 25: 2522–2528.
   PubMed Web of Science ®Google Scholar
• Glimcher, L. H., and C. J. Kara 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10: 13–49.
   PubMed Web of Science ®Google Scholar
• Gutch, M. J., and N. C. Reich 1991. Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. Proc. Natl. Acad. Sci. USA 88: 7913–7917.
   PubMed Web of Science ®Google Scholar
• Horvai, A. E., L. Xu, E. Korzus, G. Brard, D. Kalafus, T. M. Mullen, D. W. Rose, M. G. Rosenfeld, and C. K. Glass 1997. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc. Natl. Acad. Sci. USA 94: 1074–1079.
   PubMedGoogle Scholar
• Ivashkiv, L. B., and L. H. Glimcher 1991. Repression of class II major histocompatibility complex genes by cyclic AMP is mediated by conserved promoter elements. J. Exp. Med. 174: 1583–1592.
   PubMedGoogle Scholar
• Janknecht, R., and T. Hunter 1996. Transcriptional control: versatile molecular glue. Curr. Biol. 6: 951–954.
   PubMed Web of Science ®Google Scholar
• Kalvakolanu, D. V. R., S. K. Bandyopadhyay, M. L. Harter, and G. C. Sen 1991. Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation. Proc. Natl. Acad. Sci. USA 88: 7459–7463.
   PubMed Web of Science ®Google Scholar
• Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S. C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403–414.
   PubMed Web of Science ®Google Scholar
• Kee, B. L., J. Arias, and M. R. Montminy 1996. Adaptor-mediated recruitment of RNA polymerase II to a signal-dependent activator. J. Biol. Chem. 271: 2373–2375.
   PubMedGoogle Scholar
• Kim, T. K., and T. Maniatis 1997. The mechanism of transcriptional synergy of an in vitro assembled interferon-β enhanceosome. Mol. Cell 1: 119–129.
   PubMed Web of Science ®Google Scholar
• Kretsovali, A. Unpublished data.
   Google Scholar
• Louis-Plence, P., C. S. Moreno, and J. M. Boss 1997. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA Class II genes. J. Immunol. 159: 3899–3909.
   PubMedGoogle Scholar
• Lundblad, J. R., R. P. S. Kwok, M. E. Laurance, M. L. Harter, and R. H. Goodman 1995. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374: 85–88.
   PubMed Web of Science ®Google Scholar
• Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14: 301–331.
   PubMed Web of Science ®Google Scholar
• Mahanta, S. K., T. Scholl, F. C. Yang, and J. L. Strominger 1997. Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein. Proc. Natl. Acad. Sci. USA 94: 6324–6329.
   PubMedGoogle Scholar
• Meraz, M. A., J. M. White, K. C. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, and D. Campbell 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84: 431–442.
   PubMed Web of Science ®Google Scholar
• Merika, M., A. J. Williams, G. Chen, T. Collins, and D. Thanos 1998. Recruitment of CBP/p300 by the IFNβ enhanceosome is required for synergistic activation of transcription. Mol. Cell 1: 1–20.
   Google Scholar
• Montminy, M. 1997. Transcriptional regulation by cyclic AMP. Annu. Rev. Biochem. 66: 807–822.
   PubMed Web of Science ®Google Scholar
• Moreno, C. S., P. Emery, J. E. West, B. Durand, W. Reith, and B. Mach 1995. Purified X2BP cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome. J. Immunol. 155: 4313–4321.
   PubMedGoogle Scholar
• Muhlethaler-Mottet, A., W. Di Berardino, L. A. Otten, and B. Mach 1998. Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Stat1 and USF-1. Immunity 8: 157–166.
   PubMed Web of Science ®Google Scholar
• Nakajima, T., C. Uchida, S. F. Anderson, J. D. Parvin, and M. Montminy 1997. Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors. Genes Dev. 11: 738–747.
   PubMed Web of Science ®Google Scholar
• Offringa, R., S. Gebel, H. van Dam, M. Timmers, A. Smits, R. Zwart, B. Stein, J. L. Bos, A. van der Eb, and P. Herrlich 1990. A novel function of the transforming domain of Ela: repression of AP-1 activity. Cell 62: 527–538.
   PubMedGoogle Scholar
• Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatami 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953–959.
   PubMed Web of Science ®Google Scholar
• Reith, W., M. Kobr, P. Emery, B. Durand, C. A. Siegrist, and B. Mach 1994. Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters. J. Immunol. 31: 20020–20025.
   Google Scholar
• Riley, J. L., S. D. Westerheide, J. A. Price, J. A. Brown, and J. M. Boss 1995. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2: 533–543.
   PubMedGoogle Scholar
• Sadowski, I., and M. Ptashne 1989. A vector for expressing GAL4(1–147) fusions in mammalian cells. Nucleic Acids Res. 18: 7539.
   Google Scholar
• Scholl, T., S. K. Mahanta, and J. L. Strominger 1997. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA 94: 6330–6334.
   PubMedGoogle Scholar
• Schwiebert, L. M., R. P. Schleimer, S. F. Radka, and S. J. Ono 1995. Modulation of MHC class II expression in human cells by dexamethasone. Cell. Immunol. 165: 12–19.
   PubMed Web of Science ®Google Scholar
• Shikama, N., J. Lyon, and N. B. Thangue 1997. The p300/CBP family: integrating signals with transcription factors and chromatin. Trends Cell Biol. 7: 230–236.
   PubMedGoogle Scholar
• Steimle, V., C. A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach 1994. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265: 106–109.
   PubMed Web of Science ®Google Scholar
• Steimle, V., W. Reith, and B. Mach 1996. Major histocompatibility complex class II deficiency: a disease of gene regulation. Adv. Immunol. 61: 327–340.
   PubMedGoogle Scholar
• Thanos, D., G. Mavrothalassitis, and J. Papamatheakis 1988. Multiple regulatory regions on the 5′ side of the mouse E alpha gene. Proc. Natl. Acad. Sci. USA 85: 3075–3079.
   PubMed Web of Science ®Google Scholar
• Yang, X. J., V. V. Ogryzko, J. Nishikawa, B. H. Howard, and Y. Nakatami 1996. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382: 319–324.
   PubMed Web of Science ®Google Scholar
• Zhang, J. J., U. Vinkemeier, W. Gu, D. Chakravarti, C. M. Horvath, and J. E. Darnell 1996. Two contact regions between Stat1 and CBP/p300 in interferon γ signaling. Proc. Natl. Acad. Sci. USA 93: 15092–15096.
   PubMed Web of Science ®Google Scholar
• Zhou, H., and L. H. Glimcher 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2: 545–553.
   PubMedGoogle Scholar
• Zhou, H., H. S. Su, X. Zhang, Douhan J., III, and L. H. Glimcher 1997. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant. J. Immunol. 158: 4741–4749.
   PubMed Web of Science ®Google Scholar